Graf Industrial Corp. (NYSE:GRAF) announced this afternoon that it had closed its business combination with autonomous vehicle technology company Velodyne Lidar after shareholders voted to approve the deal earlier in the day.
The combined company’s shares and warrants will begin to trade on the Nasdaq under the symbols “VLDR” and “VLDRW” tomorrow, Wednesday, September 30.
The press release did not disclose the totals for the merger vote or other items on the agenda at the special meeting, but it appears that Graf was able to avoid any bumps in the road unlike some other SPACs this week.
Graf announced its business combination agreement with Velodyne Lidar July 2 and like many of the “deals with wheels” rolling through it has been positively received by the market with shares closing at $24.75.
For all of the proposals voted on in the special meeting click HERE.
Vendome Acquisition Corporation I (NASDAQ:VNMEU) announced the pricing of its $200 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “VNMEU”, Wednesday, July 2, 2025. The new SPAC plans to focus its search on target business in the consumer sector operating in North America, Southeast Asia, and Europe....
Origin Investment Corp. I (NASDAQ:ORIQU) announced the pricing of its $60 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “ORIQU”, Wednesday, July 2, 2025. The new SPAC aims to mount a broad search for a target with a strong management and both revenue and earnings growth potential....
1RT Acquisition Corp. (NASDAQ:ONCHU) announced the pricing of its $150 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “ONCHU”, Wednesday, July 2, 2025. The new SPAC plans to target company in the digital asset ecosystem involved in the creation, storage, exchange or management of such assets, whether...
D. Boral ARC Acquisition II Corp. (NASDAQ:ARBCU) has filed for a $250 million SPAC to give underwriter D. Boral a second in-house SPAC to pursue deals with. The new SPAC offers investors a 1/2 warrant and an initial 18-month time frame to complete a deal. D. Boral II’s sponsor may automatically extend this once by...
Ribbon (NASDAQ:RIBB) has entered into a definitive agreement to combine with Japanese biotech firm DRC Medicine at a pro forma equity value of $422 million. Tokyo-based DRC Medicine manufactures reusable anti-bacterial and anti-allergen wearables and aims to go deeper into the medical device and pharmaceutical space. Transaction Overview Ribbon is expected to provide $50.4 million...